DiaMedica Therapeutics
Phase 2DiaMedica Therapeutics is a biopharmaceutical company that specializes in creating synthetic proteins to treat a variety of conditions.
Founded
2000
Focus
Biologics
About
DiaMedica Therapeutics is a biopharmaceutical company that specializes in creating synthetic proteins to treat a variety of conditions.
Funding History
2Total raised: $25M
PIPE$10MUndisclosedAug 15, 2021
IPO$15MUndisclosedFeb 15, 2019
Company Info
TypePrivate
Founded2000
LocationMinneapolis, United States
StagePhase 2
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile